Tubuloglomerular feedback and salt-sensitive hypertension

肾小球反馈和盐敏感性高血压

基本信息

  • 批准号:
    9068087
  • 负责人:
  • 金额:
    $ 32.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-19 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hypertension affects over 25% of the adults and is a major cardiovascular risk to our population. More than half of hypertensive humans are salt-sensitive and have significant blood pressure fluctuations when salt intake is altered. However, the mechanisms for salt-sensitivity are not clear. Increases in glomerular filtration rate (GFR) play a vital role in the rapid elimination of sodium following acute volume expansion associated with ingestion of a sodium load, thereby contributing to restoration of sodium and water balance which maintains normal blood pressure. This GFR response is blunted in humans and in animal models with salt-sensitive hypertension. Tubuloglomerular feedback (TGF) is an essential regulator of GFR. Increasing tubular flow initiates a TGF response mediated by raising NaCl delivery to the macula densa (MD), which triggers signals that enhance the tone of the afferent arterioles and thereby reduces GFR. This fall in GFR helps restore MD flow rate toward normal and prevents marked changes in NaCl excretion. However, in persistent situations such as experimental or postprandial volume expansion, intrinsic mechanisms reset TGF, which shifts the operating point to a higher flow rate thus allowing GFR to rise. TGF resetting could facilitate the excretion of salt and water via mechanisms that may be dependent on suppression of angiotensin II and increased activity of the nitric oxide (NO) system. NO derived from the MD has been shown to dilate the afferent arteriole and blunt TGF. This NO is mainly produced by neuronal NO synthase (nNOS), which is abundantly expressed in the MD. However, the roles of the MD-delivered NO and TGF in regulation of volume homeostasis are only assumptions from these experiments. We still do not know whether NO from the MD and TGF play any roles in control of salt-water balance and blood pressure, which is the focus of this proposal. In this proposal, we will test the hypothesis that nNOS� in the MD is a salt sensitive isoform, which contributes to enhanced NO generation by the MD during high salt intake. Enhanced nNOS� activity blunts TGF and increases GFR, a mechanism which is essential in rapid elimination of a salt load and restoration of salt-water balance. Inadequate NO generation by the MD induces salt sensitive hypertension.
描述(由申请人提供):高血压影响超过25%的成年人,是我国人口的主要心血管风险。超过一半的高血压患者对盐敏感,当盐摄入量改变时,他们的血压会有明显的波动。然而,盐敏感性的机制尚不清楚。肾小球滤过率(GFR)的增加在钠负荷摄入引起的急性容量扩张后钠的快速清除中起着至关重要的作用,从而有助于恢复钠和水的平衡,维持正常血压。这种GFR反应在人类和盐敏感性高血压动物模型中减弱。管肾小球反馈(TGF)是GFR的重要调节因子。增加的管状血流通过增加向黄斑致密(MD)的NaCl递送介导TGF反应,从而触发信号,增强传入小动脉的张力,从而降低GFR。GFR的下降有助于将MD流速恢复到正常水平,并防止NaCl排泄的显著变化。然而,在持续的情况下,如实验或餐后体积膨胀,内在机制重置TGF,将工作点转移到更高的流量,从而使GFR上升。TGF复位可以促进

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of different storage solutions on renal ischemia tolerance after kidney transplantation in mice.
  • DOI:
    10.1152/ajprenal.00475.2017
  • 发表时间:
    2018-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lei Wang;Jin Wei;Shan Jiang;Huihui Li;L. Fu;Jie Zhang;Ruisheng Liu
  • 通讯作者:
    Lei Wang;Jin Wei;Shan Jiang;Huihui Li;L. Fu;Jie Zhang;Ruisheng Liu
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RUISHENG LIU其他文献

RUISHENG LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RUISHENG LIU', 18)}}的其他基金

Treatment of lupus nephritis with nanoparticles that selectively target kidney glomeruli
用选择性靶向肾小球的纳米颗粒治疗狼疮性肾炎
  • 批准号:
    10679184
  • 财政年份:
    2023
  • 资助金额:
    $ 32.52万
  • 项目类别:
Tubuloglomerular feedback response in AKI to CKD transition
AKI 向 CKD 转变中的肾小球反馈反应
  • 批准号:
    10533630
  • 财政年份:
    2022
  • 资助金额:
    $ 32.52万
  • 项目类别:
Role of tubuloglomerular feedback in the development of hypertension in diabetes
肾小球反馈在糖尿病高血压发生中的作用
  • 批准号:
    9917816
  • 财政年份:
    2019
  • 资助金额:
    $ 32.52万
  • 项目类别:
Role of tubuloglomerular feedback in the development of hypertension in diabetes
肾小球反馈在糖尿病高血压发生中的作用
  • 批准号:
    10394215
  • 财政年份:
    2019
  • 资助金额:
    $ 32.52万
  • 项目类别:
Renal hemodynamics and hypertension during pregnancy
妊娠期肾脏血流动力学和高血压
  • 批准号:
    10090619
  • 财政年份:
    2018
  • 资助金额:
    $ 32.52万
  • 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
  • 批准号:
    8895614
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
  • 批准号:
    8692309
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
  • 批准号:
    8817288
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
  • 批准号:
    9282582
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:
Primary cilia and modulation of the renal microcirculation
原发纤毛和肾微循环的调节
  • 批准号:
    9068089
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了